Bulletin of Experimental Biology and Medicine.
New York Consultants BureauSpringer / Автономная некоммерческая организация Издательство Российской академии медицинских наук.
Vol. 153.
2012.
P. 825-827
The study demonstrated possible design of a medicinal formulation in the form of suppositories comprising human recombinant interferon-α2 and dry aloe extract. The approaches to the development of the suppositories were technology - derived. No interaction between the active and auxiliary components was proved by solid state 1H-NMR spectroscopy. The specific activity of the drug was investigated.